Symbol="APLS"
AssetType="Common Stock"
Name="Apellis Pharmaceuticals Inc"
Description="Apellis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic compounds through inhibition of the complement system for autoimmune and inflammatory diseases. The company is headquartered in Waltham, Massachusetts."
CIK="1492422"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6400 WESTWIND WAY, SUITE A, CRESTWOOD, KY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="10025782000"
EBITDA="-639102016"
PERatio="None"
PEGRatio="None"
BookValue="3.547"
DividendPerShare="0"
DividendYield="0"
EPS="-6.08"
RevenuePerShareTTM="0.962"
ProfitMargin="0"
OperatingMarginTTM="-6.05"
ReturnOnAssetsTTM="-0.377"
ReturnOnEquityTTM="-1.581"
RevenueTTM="105887000"
GrossProfitTTM="69786000"
DilutedEPSTTM="-6.08"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.118"
AnalystTargetPrice="102"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="51.26"
PriceToBookRatio="17.67"
EVToRevenue="42.79"
EVToEBITDA="-8.03"
Beta="1.268"
num_52WeekHigh="94.75"
num_52WeekLow="42.15"
num_50DayMovingAverage="88.0"
num_200DayMovingAverage="65.91"
SharesOutstanding="116457000"
DividendDate="None"
ExDividendDate="None"
symbol="APLS"
open="84.55"
high="87.51"
low="84.20"
price="86.62"
volume="836766.00"
latest_trading_day="2023-07-10"
previous_close="86.09"
change="0.53"
change_percent="0.6156%"
aroon_positive_momentum_days="100"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="100"
Volume_recent_avg="1796236"
Change_recent_avg="0.34"
Delta_recent_avg="2.92"
Variance_recent_avg="1.46"
Change_ratio_recent_avg="0.42"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="100"
Aroon_momentum_negative="0"
image_negative_thumbnail_id_1="490"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0115.jpeg"
image_negative_thumbnail_id_2="99"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0077.jpeg"
image_neutral_thumbnail_id_1="569"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_neutral_thumbnail_id_2="598"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0001.jpeg"
image_positive_thumbnail_id_1="689"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0019.jpeg"
image_positive_thumbnail_id_2="978"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0140.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
